VEA
GRCL

Virtus ETF Advisers’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Virtus ETF Advisers’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,728
Closed -$58K – 489
2022
Q1 		$58K Sell
24,728
-1,469
-6% -$3.45K 0.03% 362
2021
Q4 		$158K Buy
26,197
+11,589
+79% +$69.9K 0.06% 332
2021
Q3 		$203K Sell
14,608
-755
-5% -$10.5K 0.09% 266
2021
Q2 		$200K Buy
+15,363
New +$200K 0.08% 350